Prevention and control of schistosomiasis: a current perspective

References

• World Health Organization. Schistosomiasis Progress Report (2001−2011) and Strategic Plan (2012−2020). Geneva, Switzerland: World Health Organization Press; 2013 Available from: http://www.who.int/schistosomiasis/resources/en/. Accessed December 9, 2013.
   Google Scholar
• Barry MA, Simon GG, Mistry N, Hotez PJ. Global trends in neglected tropical disease control and elimination: impact on child health. Arch Dis Child. 2013;98(8):635–641.23793132
   PubMed Web of Science ®Google Scholar
• Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis. 2007;7:1(2):e114.
   Web of Science ®Google Scholar
• World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization Press; 2008 Available from: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/. Accessed July 16, 2014.
   Google Scholar
• King CH. Parasites and poverty: the case of schistosomiasis. Acta Trop. 2010;113(2):95–104.19962954
   PubMed Web of Science ®Google Scholar
• Gryseels B, Strickland GM. Schistosomiasis In: Magill AJ, Hill DR, Solomon T, Ryan ET, editors. Hunter’s Tropical Medicine and Emerging Infectious Disease. 9th ed. Philadelphia, PA, USA: Elsevier; 2013.
   Google Scholar
• Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012;26(2): 383–397.22632645
   PubMed Web of Science ®Google Scholar
• Gordon CA, Acosta LP, Gray DJ, et al High prevalence of Schistosoma japonicum infection in carabao from Samar Province, the Philippines: implications for transmission control. PLoS Negl Trop Dis. 2012;6(9):e1778.23029571
   PubMed Web of Science ®Google Scholar
• Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis. 2007;7(3):218–224.17317603
   PubMed Web of Science ®Google Scholar
• Curwen RS, Wilson RA. Invasion of skin by schistosome cercariae: some neglected facts. Trends Parasitol. 2003;19(2):63–66.12586470
   PubMed Web of Science ®Google Scholar
• He YX, Salafsky B, Ramaswany K. Comparison of skin invasion among three major species of Schistosoma. Trends Parasitol. 2005;21(5):201–203.15837605
   PubMed Web of Science ®Google Scholar
• Maguire JH. Trematodes (schistosomes and other flukes) In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and Practices of Infectious Diseases. 7th ed. Philadelphia, PA, USA: Elsevier; 2010.
   Google Scholar
• Holick DS, Kaul TL. Schistosomiasis. Urol Nurs. 2013;33(4): 163–170.24079113
   PubMedGoogle Scholar
• Bustinduy AL, King CH. Schistosomiasis In: Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ, editors. Manson’s Tropical Disease. 23rd ed. Philadelphia, PA, USA: Elsevier; 2014.
   Google Scholar
• Boros DL. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev. 1989;2(3):250–269.2504481
   PubMed Web of Science ®Google Scholar
• Hams E, Aviello G, Fallon PG. The schistosoma granuloma: friend or foe? Front Immunol. 2013;4:89.23596444
   PubMed Web of Science ®Google Scholar
• Ross AG, Bartley PB, Sleigh AC, et al Schistosomiasis. N Engl J Med. 2002;346(16):1212–1220.11961151
   PubMed Web of Science ®Google Scholar
• Li Y, Chen D, Ross AG, et al Severe hepatosplenic schistosomiasis: clinicopathologic study of 102 cases undergoing splenectomy. Hum Pathol. 2011;42(1):111–119.20970162
   PubMed Web of Science ®Google Scholar
• Nascimento-Carvalho CM, Moreno-Carvalho OA. Neuroschistosomiasis due to Schistosoma mansoni: a review of pathogenesis, clinical syndromes and diagnostic approaches. Rev Inst Med Trop Sao Paulo. 2005;47(4):179–184.16138195
   PubMedGoogle Scholar
• World Health Organization. Schistosomiasis: number of people treated in 2012. Wkly Epidemiol Rec. 2014;89(4):21–28.24446558
   PubMedGoogle Scholar
• Reich MR, Govindaraj R, Dumbaugh K, et al In: Reich MR, editor. International Strategies for Tropical Disease Treatment: Experiences with Praziquantel. Geneva, Switzerland: World Health Organization; 1998.
   Google Scholar
• Chai JY. Praziquantel treatment in trematode and cestode infections: an update. Infect Chemother. 2013;45(1):32–43.24265948
   PubMedGoogle Scholar
• Obonyo CO, Muok EM, Mwinzi PN. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: an open-label randomized controlled trial. Lancet Infect Dis. 2010;10(9):603–611.20705516
   PubMed Web of Science ®Google Scholar
• Erko B, Degarege A, Tadesse K, Mathiwos A, Legesse M. Efficacy and side effects of praziquantel treatment of Schistosomiasis mansoni in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia. Asian Pac J Trop Biomed. 2012;2(3):235–239.23569905
   PubMedGoogle Scholar
• Reta B, Erko B. Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete Town, northeastern Ethiopia. Trop Med Int Health. 2013;18(11):1338–1343.24103059
   PubMed Web of Science ®Google Scholar
• Coulibaly JT, N’Gbesso YK, Knopp S, Keiser J, N’Goran EK, Utzinger J. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLoS Negl Trop Dis. 2012;6(12):e1917.23236526
   PubMed Web of Science ®Google Scholar
• Borrmann S, Szlezak N, Faucher JF, et al Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. J Infect Dis. 2001;184(10):1363–1366.11679932
   PubMed Web of Science ®Google Scholar
• Keiser J, N’Guessan NA, Adoubryn KD, et al Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis. 2010;50(9):1205–1213.20350194
   PubMed Web of Science ®Google Scholar
• Sissoko MS, Dabo A, Traore H, et al Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One. 2009;4(10):e6732.19802383
   PubMed Web of Science ®Google Scholar
• Tchuente LA, Shaw DJ, Polla L, Cioli D, Vercruysse J. Efficacy of praziquantel against Schistosoma haematobium infection in children. Am J Trop Med Hyg. 2004;71(6):778–782.15642971
   PubMed Web of Science ®Google Scholar
• Guidi A, Andolina C, Makame Ame S, Albonico M, Cioli D, Juma Haji H. Praziquantel efficacy and long-term appraisal of schistosomiasis control in Pemba Island. Trop Med Int Health. 2010;15(5):614–618.20214757
   PubMed Web of Science ®Google Scholar
• Sousa-Fugueiredo JC, Betson M, Atuhaire A, et al Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis. 2012;6(10):e1864.23094120
   PubMed Web of Science ®Google Scholar
• Garba A, Lamine MS, Barkire N, et al Efficacy and safety of two closely spaced doses of praziqauntel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger. Acta Trop. 2013;128(2):334–344.22940014
   PubMed Web of Science ®Google Scholar
• Tchuem Tchuente LA, Momo SC, Stothard JR, Rollinson D. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon. Acta Trop. 2013;128(2):275–283.23791803
   PubMed Web of Science ®Google Scholar
• Olliare PL, Vaillant MT, Belizario VJ, et al A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLos Negl Trop Dis. 2011;5(6):e1165.21695161
   PubMed Web of Science ®Google Scholar
• Gray DJ, Ross AG, Li YS, McManus DP. Diagnosis and management of schistosomiasis. BMJ. 2011;342:d2651.21586478
   PubMed Web of Science ®Google Scholar
• Ferrari ML, Coelho PM, Antunes CM, Tavares CA, da Cunha AS. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull World Health Organ. 2003;81(3):190–196.12764515
   PubMed Web of Science ®Google Scholar
• Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis. 2008;21(6):659–667.18978535
   PubMed Web of Science ®Google Scholar
• Utzinger J, N’Goran EK, N’Dri A, Xiao S, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomized controlled trial. Lancet. 2000;355(9212):1320–1325.10776745
   PubMed Web of Science ®Google Scholar
• Araujo N, Kohn A, Katz N. Activity of the artemether in experimental schisosomiasis mansoni. Mem Inst Oswaldo Cruz. 1991;86 Suppl 2: 185–188.1841998
   PubMed Web of Science ®Google Scholar
• Hou XY, McManus DP, Gray DJ, et al A randomized double-blind placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute Schistosomiasis japonica in China. Bull World Health Organ. 2008;86(10):788–795.18949216
   PubMed Web of Science ®Google Scholar
• Utzinger J, Tanner M, Keiser J. ACTs for schistosomiasis: do they act? Lancet Infect Dis. 2010;10(9):579–581.20705514
   PubMed Web of Science ®Google Scholar
• Abay SM, Tilahun M, Fikrie N, Habtewold A. Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients. J Infect Dev Ctries. 2013;7(6):468–474.23771290
   PubMed Web of Science ®Google Scholar
• Ross AG, McManus DP, Farrar J, Huntsman RJ, Gray DJ, Li YS. Neuroschistosomiasis. J Neurol. 2012;259(1):22–32.21674195
   PubMed Web of Science ®Google Scholar
• Miller MJ, Reid EC. Steroid therapy in chronic urinary schistosomiasis (bilharziasis). Can Med Assoc J. 1967;97(11):594–599.6050892
   PubMed Web of Science ®Google Scholar
• Badr HI, Shaker AA, Mansour MA, et al Schistosomal myeloradiculopathy due to Schistosoma mansoni: report on 17 cases from an endemic area. Ann Indian Acad Neurol. 2011;14(2):107–110.21808472
   PubMed Web of Science ®Google Scholar
• Fowler R, Lee C, Keystone JS. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg. 1999;61(1):47–50.10432054
   PubMed Web of Science ®Google Scholar
• Lambertucci JR, Voieta I, Silveira Idos S. Cerebral schistososomiasis mansoni. Rev Soc Bras Med Trop. 2008;41(6):693–694.19142458
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Parasites – schistosamiasis. Available from http://www.cdc.gov/parasites/schistosomiasis/ Accessed January 25, 2014.
   Google Scholar
• Montgomery S. Infectious diseases related to travel: schistosomiasis. In: CDC Health Information for International Travel. Available from http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-disease-related-to-travel/schistosomiasis Accessed April 15, 2014.
   Google Scholar
• Stothard JR, Figueiredo JC, Navaratnam AM. Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis. Expert Rev Anti Infect Ther. 2013:11(7): 733–752.23879611
   PubMed Web of Science ®Google Scholar
• World Health Organization. Schistosomiasis: number of people treated in 2010. Wkly Epidemiol Rec. 2012;87(4):37–44.22308580
   PubMedGoogle Scholar
• Humphries D, Nguyen S, Boakye D, Wilson M, Capello M. The promise and pitfalls of mass drug administration to control infections. Curr Opin Infect Dis. 2012;25(5):584–589.22903231
   PubMed Web of Science ®Google Scholar
• King CH. Toward the elimination of schistosomiasis. N Engl J Med. 2009;360(2):106–109.19129524
   PubMed Web of Science ®Google Scholar
• World Health Organization. Preventive chemotherapy in human helminthiasis coordinated use of antihelmintic drugs in control interventions: a manual for health professionals and programme managers. Geneva, Switzerland: World Health Organization; 2006 Available from: http://whqlibdoc.who.int/publications/2006/9241547103_eng.pdf.Accessed July 16, 2014.
   Google Scholar
• Hodges MH, Dada N, Warmsley A, et al Mass drug administration significantly reduces Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone. BMC Infect Dis. 2012;12:16.22264258
   PubMed Web of Science ®Google Scholar
• Koukounari A, Gabrielli AF, Toure S, et al Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis. 2007;196(5):659–669.17674306
   PubMed Web of Science ®Google Scholar
• Sarvel AK, Oliveira AA, Silva AR, Lima AC, Katz N. Evaluation of a 25-year program for the control of schistosomiasis mansoni in an endemic are in Brazil. PLoS Negl Trop Dis. 2011;5(3):e990.21423644
   PubMed Web of Science ®Google Scholar
• Sesay S, Paye J, Bah MS, et al Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone. Parasit Vectors. 2014;7:14.24401567
   PubMed Web of Science ®Google Scholar
• Garba A, Toure S, Dembele R, et al Present and future schistosomiasis control activities with support from Schistosomiasis Control Initiative in West Africa. Parasitology. 2009;136(13):1731–1737.19631007
   PubMed Web of Science ®Google Scholar
• Fenwick A, Webster JP. Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis. 2006;19(6):5775–5782.
   Web of Science ®Google Scholar
• Gray DJ, McManus DP, Li Y, Williams GM, Berqquist R, Ross AG. Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis. 2010;10(10):733–736.20705513
   PubMed Web of Science ®Google Scholar
• Tallo VL, Carabin H, Alday PP, Balolong E Jr, Olveda RM, McGarvey ST. Is mass treatment the appropriate schistosomiasis elimination strategy? Bull World Health Organ. 2008;86(10):765–771.18949213
   PubMed Web of Science ®Google Scholar
• Yang GJ, Li W, Sun LP, et al Molluscicidal efficacies of different formulations of niclosamide: result of meta-analysis of Chinese literature. Parasit Vectors. 2010;3:84.20819229
   PubMed Web of Science ®Google Scholar
• Barbosa FS, Coimbra CE Jr. Alternative approaches in schistosomiasis control. Mem Inst Oswaldo Cruz. 1992;87 Suppl 4: 215–220.1343898
   PubMed Web of Science ®Google Scholar
• McCullough FS, Gayral P, Duncan J, Christie JD. Molluscicides in schistosomiasis control. Bull World Health Organ. 1980;58(5):681–689.6975179
   PubMed Web of Science ®Google Scholar
• Yang GJ, Sun LP, Hong QB. Optimizing molluscicide treatment strategies in different control stages of schistosomiasis in the People’s Republic of China. Parasit Vectors. 2012;5:260.23151396
   PubMed Web of Science ®Google Scholar
• Madsen H. Ecological studies on the intermediate host snails and the relevance to schistosomiasis control. Mem Inst Oswaldo Cruz. 1992;87 Suppl 4: 249–253.
   Web of Science ®Google Scholar
• Mazigo HD, Nuhawa F, Kinung’hi SM, et al Epidemiology and control of human schistosomiasis in Tanzania. Parasit Vectors. 2012;5:274.23192005
   PubMed Web of Science ®Google Scholar
• Wang LD, Chen HG, Guo JG, et al A strategy to control transmission of Schistosoma japonicum in China. N Engl J Med. 2009;360(2): 121–128.19129526
   PubMed Web of Science ®Google Scholar
• Sleigh A, Li X, Jackson S, Huang K. Eradication of schistosomiasis in Guangxi, China. Part 1: Setting, strategies, operations, and outcomes, 1953–1992. Bull World Health Organ. 1998;76(4):361–372.9803587
   PubMed Web of Science ®Google Scholar
• Colley DG, Bustunduy AL, Secor WE, King CH. Human schistostomiasis. Lancet. 2014;383(9936):2253–2264.24698483
   PubMed Web of Science ®Google Scholar
• Kosinski KC, Adjei MN, Bosompen KM, et al Effective control of Schistosoma haematobium infection in a Ghanaian community following installation of a water recreation area. PLoS Negl Trop Dis. 2012;6(7):e1709.22815999
   PubMed Web of Science ®Google Scholar
• World Health Organization. Helminth Control in School-Age Children: A Guide for Managers of Control Programmes. 2nd ed. Geneva, Switzerland: World Health Organization; 2011 Available from: http://whqlibdoc.who.int/publications/2011/9789241548267_eng.pdf.Accessed July 16, 2014.
   Google Scholar
• McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev. 2008;21(1):225–242.18202444
   PubMed Web of Science ®Google Scholar
• Bethony JM, Cole RN, Guo X, et al Vaccines to combat the neglected diseases. Immunol Rev. 2011;239(1):237–270.21198676
   PubMed Web of Science ®Google Scholar
• Beaumer CM, Gillespie PM, Hotez PJ, Bottazi ME. New vaccines for neglected parasitic diseases and dengue. Transl Res. 2013;162(3): 144–155.23578479
   PubMed Web of Science ®Google Scholar
• World Health Organization. Model List of Essential Medicines. Geneva, Switzerland: World Health Organization; 2011 Available from: http://whqlibdoc.who.int/hq/2011/a95053_eng.pdf?ua=1. Accessed February 15, 2014.
   Google Scholar
• World Health Organization. Expert Committee on the Control of Schistosomiasis. Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis: Report of a Who Expert Committee. 2nd ed. Geneva, Switzerland: World Health Organization; 2002.
   Google Scholar